Health
New York: A World Health Organization (WHO) expert panel issued its first guidance on the Moderna COVID-19 vaccine on Tuesday, saying that it should ideally be given to people in two separate doses, 28 days apart. In exceptional circumstances this period could be extended to 42 days, said WHO’s advisory group of experts on immunization, SAGE, amid supply shortages affecting many countries. more
As COVID deaths pass two million worldwide, Guterres warns against self-defeating ‘vaccinationalism'

New York: With more than two million lives now lost worldwide to COVID-19, the UN Secretary-General appealed on Friday for countries to work together and help each other to end the pandem ...

Brazil results show China's Sinovac vaccine is just 50.4 percent effective against COVID-19

Brazilian clinical trials have unveiled that a COVID-19 vaccine developed by China's Sinovac has been found to be 50.4% effective, media reports said.

NHS England issues call to start staffing COVID-19 vaccination points by Dec 14: Reports

Moscow/Sputnik: Public health officials in England have called on general practitioners to begin staffing local COVID-19 vaccination centers by December 14, the Sky News broadcaster repor ...

Pfizer to only get half of COVID-19 vaccines out this year due to logistics: Reports

Washington/Sputnik: US drug giant Pfizer expects to ship just about half of the COVID-19 vaccines it originally planned for this year because of supply-chain problems, although it still e ...

‘Real hope’ surrounding COVID vaccines ‘cannot be overstated’ – WHO chief

New York: Along with other tried and tested public health measures, the head of the World Health Organization (WHO) told journalists on Monday that “there is now real hope” th ...

UNICEF planning 'mammoth operation' to deliver COVID-19 vaccines

New York: UN Children’s Fund (UNICEF) is working with more than 350 logistics partners, including major airlines, shipping lines and logistics associations from around the world, to ...

COVID-19: Oxford vaccine shows 70 percent efficiency 

London: Oxford University’s AstraZeneca vaccine candidate, AZD1222, which is being developed against COVID-19 disease has shown 70 percent efficiency on average, officials said.

US official expects COVID-19 vaccination to start on December 11

Moscow/Sputnik: The first US citizens to receive Pfizer's COVID-19 vaccines may get the inoculation shot December 11, Operation Warp Speed chief adviser Moncef Slaoui told CNN on Sund ...

Pfizer launches pilot COVID-19 vaccine distribution preparedness program in 4 US states

Moscow/Sputnik: US pharmaceutical company Pfizer announced in a press release on Tuesday it was launching a pilot program that aims to inform the delivery and distribution of its coronavi ...